Literature DB >> 24900580

Fighting Obesity and Metabolic Disorders with MGAT-2 Inhibitors.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2013        PMID： 24900580      PMCID： PMC4027406          DOI： 10.1021/ml400272q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: a model for congenital disorder of glycosylation type IIa.

Authors:  Yan Wang; Harry Schachter; Jamey D Marth
Journal:  Biochim Biophys Acta       Date:  2002-12-19

Review 2.  Glycerolipid acyltransferases in triglyceride metabolism and energy homeostasis-potential as drug targets.

Authors:  Guoqing Cao; Robert J Konrad; Shuyu D Li; Craig Hammond
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2012-06       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.